Motif ID: Nfatc3
Z-value: 1.110

Transcription factors associated with Nfatc3:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Nfatc3 | ENSMUSG00000031902.9 | Nfatc3 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nfatc3 | mm10_v2_chr8_+_106059562_106059623 | 0.27 | 2.2e-02 | Click! |
Top targets:
Showing 1 to 20 of 200 entries
Gene overrepresentation in biological_process category:
Showing 1 to 20 of 140 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 13.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.7 | 13.0 | GO:0032060 | bleb assembly(GO:0032060) |
4.0 | 12.1 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.1 | 9.6 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
3.0 | 9.0 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
1.3 | 7.9 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.5 | 7.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.6 | 7.4 | GO:0032808 | lacrimal gland development(GO:0032808) enteric nervous system development(GO:0048484) |
2.4 | 7.3 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.7 | 7.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.4 | 6.4 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
1.5 | 6.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
1.2 | 6.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.9 | 5.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.3 | 5.1 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.2 | 5.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.5 | 4.9 | GO:0070836 | caveola assembly(GO:0070836) |
1.6 | 4.7 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
1.5 | 4.6 | GO:0021557 | oculomotor nerve development(GO:0021557) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.1 | 4.5 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
Gene overrepresentation in cellular_component category:
Showing 1 to 20 of 74 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 18.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 13.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.5 | 13.0 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 11.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.9 | 8.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.9 | 7.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 5.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 5.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 4.7 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 4.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 4.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 4.2 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 4.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 3.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 3.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.4 | 3.6 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 3.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 3.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.6 | 3.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 2.8 | GO:0042382 | paraspeckles(GO:0042382) |
Gene overrepresentation in molecular_function category:
Showing 1 to 20 of 115 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 12.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.4 | 10.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 10.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.4 | 9.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 8.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.7 | 7.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
2.4 | 7.3 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
1.4 | 7.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 7.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.2 | 6.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 6.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 6.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 5.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.6 | 5.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
1.7 | 5.1 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.8 | 5.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.0 | 4.4 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 4.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 4.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 4.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |